First Tracks Biotherapeutics Inc. (TRAX) Live Share Price, Invest From India

First Tracks Biotherapeutics Inc. Stock Performance

as on July 23, 2026 at 5:09 am IST

Day's Low
Day's High
$35.11
Day's Price Range
$39.43
$37.73
6.94%
Downside
4.51%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$37.73
100.00%
Downside
-100.00%
Upside

First Tracks Biotherapeutics Inc. share price movements today

Previous Close: $37.37
Open: $36.30
Volume: 681.9K
Day's Low - High: $35.11 - $39.43

First Tracks Biotherapeutics Inc. Historical Returns

1 Month Return: + 103.98 %
3 Month Return: + 98.04 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

First Tracks Biotherapeutics Inc. Stock Fundamentals & Key Indicators

Check First Tracks Biotherapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

-3.6015

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-48.92%

First Tracks Biotherapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of First Tracks Biotherapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
First Tracks Biotherapeutics Inc.	NA	$1.3B	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$38.4B	539.31%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.0B	145.89%	28.82	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$70.5B	15.05%	16.53	29.65%	0.53%

Indian Investors' Interest in First Tracks Biotherapeutics Inc. Stock

Search interest for First Tracks Biotherapeutics Inc. Stock has increased by 6480% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 22, 2026 to July 22, 2026

Change:6480% versus previous 30 day period

First Tracks Biotherapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Mar 2026
Total Revenue	-	-
Gross Profit	-	-
Operating Income	-51	-52
EBITDA	-50	-52
Interest Expense	-	-
Depreciation	0	0
Income Before Tax	-47	-50
Income Tax Expense	-	-
Net Income	-47	-50
Net Profit Margin	0.00%	0.00%

First Tracks Biotherapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024
Total Revenue	-	-
Gross Profit	-	-152
Operating Income	-118	-181
EBITDA	-116	-178
Interest Expense	-	-
Depreciation	2	2
Income Before Tax	-106	-163
Income Tax Expense	-	-
Net Income	-106	-163
Net Profit Margin	0.00%	0.00%

First Tracks Biotherapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2026
Net Income	-50
Operating Cash Flow	-32
Investing Cash Flow	34
Financing Cash Flow	7
Change in Cash	10

First Tracks Biotherapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2024	Dec 2025
Net Income	-163	-166
Operating Cash Flow	-125	-142
Investing Cash Flow	95	228
Financing Cash Flow	117	30
Change in Cash	87	115

Global Institutional Holdings in First Tracks Biotherapeutics Inc.

Funds	Holdings
Financial Enhancement Group LLC	0.21%
Tema ETFs	0.09%
Y-Intercept (Hong Kong) Ltd	0.08%
GAMMA Investing LLC	0%
MASSMUTUAL TRUST CO FSB/ADV	0%

Insights on First Tracks Biotherapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, TRAX stock has moved up by 104.0%

About First Tracks Biotherapeutics Inc.

First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. Its products includes ANB033, a novel anti-CD122 antagonist that targets the shared beta subunit of the IL-15 and IL-2 receptors; Rosnilimab, a antibody engineered to selectively deplete pathogenic T cells in both the periphery and inflamed tissues; and ANB101, a BDCA2-modulating antibody designed to specifically target plasmacytoid dendritic cells (pDCs). First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was founded in 2019 and is based in San Diego, California.

Organisation	First Tracks Biotherapeutics Inc.
Headquarters	10770 Wateridge Circle, San Diego, CA, United States, 92121
Industry	Biotechnology
CEO	Mr. Daniel R. Faga
E-voting on shares	Click here to vote

Key Management of First Tracks Biotherapeutics Inc.

Name	Title
Mr. Daniel R. Faga	CEO, President & Director
Dr. Paul F. Lizzul M.D.	Chief Medical Officer
Mr. Ajim A. Tamboli C.F.A.	Chief Financial Officer
Mr. Benjamin Stone	Chief Business Officer
Mr. Eric J. Loumeau	Secretary

FAQs

What is First Tracks Biotherapeutics Inc. share price today?

First Tracks Biotherapeutics Inc. share price today is $37.73 as on July 22, 2026 at 11:39 pm IST. First Tracks Biotherapeutics Inc. share today touched a day high of $39.43 and a low of $35.11.

What is the 52 week high and 52 week low for First Tracks Biotherapeutics Inc. share?

First Tracks Biotherapeutics Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. First Tracks Biotherapeutics Inc. stock price today i.e. July 22, 2026 at 11:39 pm IST is trending at $37.73,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is First Tracks Biotherapeutics Inc.'s market capitalisation today?

First Tracks Biotherapeutics Inc. market capitalisation is $0.00T as on July 22, 2026 at 11:39 pm IST.

How to invest in First Tracks Biotherapeutics Inc. Stock (TRAX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for First Tracks Biotherapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in First Tracks Biotherapeutics Inc. Shares that will get you 0.0398 shares as per First Tracks Biotherapeutics Inc. share price of $37.73 per share as on July 22, 2026 at 11:39 pm IST.

What is the minimum amount required to buy First Tracks Biotherapeutics Inc. Stock (TRAX) from India?

Indian investors can start investing in First Tracks Biotherapeutics Inc. (TRAX) shares with as little as ₹96.565 or $1 (as of July 22, 2026 at 11:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹965.65 in First Tracks Biotherapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 22, 2026 at 11:40 pm IST). Based on First Tracks Biotherapeutics Inc. share’s latest price of $37.73 as on July 22, 2026 at 11:39 pm IST, you will get 0.2650 shares of First Tracks Biotherapeutics Inc.. Learn more about fractional shares .